Jamie Macdonald has been appointed president and chief executive officer of INC Research LLC. Mr. Macdonald currently serves as chief operating officer and has been central to the leadership of INC Research and a key architect of the company's growth strategy. Mr. Macdonald will take over for James T. Ogle, who will continue to serve as chairman of the company.
Alistair Macdonald has been named chief operating officer. He currently serves as president of Clinical Development Services and has 20 years of experience in the CRO industry, including 10 years with INC Research. Mr. Ogle, Mr. Jamie Macdonald and Mr. Alistair Macdonald will assume their new roles Jan. 1, 2013.
Mr. Ogle recently completed his ninth year as chief executive officer and has served as a member of the company's board of directors since 2003. He has 25 years of experience in the CRO and biopharmaceutical industries.
"On behalf of the board of directors, we would like to take this opportunity to recognize Jim Ogle's tremendous contributions to INC Research," said David Burgstahler, president and partner, Avista Capital Partners and INC Research Board member. "During his tenure, the Company grew from 225 employees to nearly 5,000 today across six continents, with customers including all of the top 10 biopharmaceutical companies worldwide."
"I am proud of our accomplishments during my time at INC Research and the efforts of our many talented employees across the globe who are dedicated in their efforts every day to help our customers bring new life-saving and life-enhancing therapies to market," said James Ogle. "A results-driven leader, Jamie Macdonald brings to the CEO position proven CRO industry operational and financial leadership experience, exceptional strategic insight and a relentless drive to achieve service excellence for our customers. We have every confidence in his ability to navigate INC Research through the next phase of our growth as we expand our leadership position."